Anne Paakinaho

Epigenetic Upregulation of Endogenous VEGF-A Reduces Myocardial Infarct Size in Mice

M. Turunen, S. Ylä-Herttuala, E. Gao, 2014, PloS one.

Identification of Drugs Associated with Lower Risk of Parkinson’s Disease Using a Systematic Screening Approach in a Nationwide Nested Case–Control Study

S. Hartikainen, A. Tolppanen, M. Koponen, 2022, Clinical epidemiology.

CLEP_A_381289 1217..1227

S. Hartikainen, A. Tolppanen, M. Koponen, 2022 .

Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease

S. Hartikainen, M. Kauppi, A. Tolppanen, 2022, Neurology.

Hospitalization and the Risk of Initiation of Antipsychotics in Persons With Parkinson's Disease.

S. Hartikainen, A. Tolppanen, M. Tiihonen, 2023, Journal of the American Medical Directors Association.

Incidence of muscle relaxant use in relation to diagnosis of Parkinson’s disease

S. Hartikainen, H. Taipale, A. Tolppanen, 2020, International Journal of Clinical Pharmacy.

β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson’s Disease: Nested Case-Control Study

J. Tiihonen, S. Hartikainen, H. Koskela, 2023, Clinical epidemiology.

Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease: Nested Case-Control Study of People With Rheumatoid Arthritis

Anne Paakinaho, MSc Pharm, PhD Pharm Marjaana Koponen, 2022 .